Background
==========

In addition to the canonical ribonucleoside and deoxyribonucleoside phosphates and cofactors, cells contain a large number of minor nucleotides. Among these are the diadenosine polyphosphates (Ap~n~A, where n = 2--7 \[[@B1]\]). Ap~3~A and Ap~4~A are the most intensively studied of these and are generally present in the soluble fraction of eukaryotic and prokaryotic cells at concentrations between 10 nM and 5 μM \[[@B2]\]. Platelet dense granules, adrenal chromaffin granules and certain synaptic vesicles have been reported to contain high concentrations of Ap~5~A and Ap~6~A in addition to Ap~3~A and Ap~4~A, all of which can be exocytosed following appropriate stimuli and bind to target cell purinoceptors causing a variety of physiological responses in the cardiovascular and central and peripheral nervous systems \[[@B1],[@B3]-[@B5]\]. However, although Ap~6~A has been detected in erythrocytes \[[@B6]\], there are no substantiated measurements of Ap~5~A and Ap~6~A in the soluble fraction of nucleated cells, and it is likely that they are typically present at concentrations much lower than those of Ap~3~A and Ap~4~A. The estimated 7 μM Ap~5~A reported in cardiac muscle \[[@B7]\] may also be confined to granules.

Whilst the extracellular diadenosine polyphosphates have partially characterised signalling properties, the possible functions of the soluble, intracellular compounds remain unclear. On the one hand, they may simply be by-products of several enzymic reactions (e.g. those catalysed by aminoacyl-tRNA synthetases and other ligases \[[@B8]\]). On the other, they may have one or more of a number of important regulatory roles, including involvements in DNA replication/repair, metabolic stress responses, the determination of cellular fate, and the regulation of enzyme activities and ion channels (see \[[@B1]\]). For example, Ap~5~A is a potent inhibitor of adenylate kinase \[[@B9]\].

It is clear that cells have a variety of relatively specific enzymes able to degrade these compounds. These include symmetrically-cleaving Ap~4~A hydrolases (in prokaryotes), members of the histidine triad protein family such as the FHIT tumour suppresser protein and (in lower eukaryotes) the related Ap~4~A phosphorylases, and most widespread of all, members of the Nudix hydrolase family (see \[[@B10],[@B11]\] for reviews). Nudix hydrolases cleave predominantly the diphosphate linkage in compounds of general structure: [n]{.ul}ucleoside [d]{.ul}iphosphate linked to another moiety, [X]{.ul}. Some family members have a relatively broad substrate specificity, while others have a much more restricted range. They all possess the Nudix sequence signature motif Gx~5~Ex~5~ \[UA\]xREx~2~EexGU (where U is an aliphatic hydrophobic amino acid), which represents the catalytic site of the enzyme. Animal and plant Ap~4~A hydrolases (EC 3.1.6.17) degrade Ap~4~A, Ap~5~A and Ap~6~A, always producing ATP as one of the products. They are most active towards Ap~4~A; however, the related enzymes from *Escherichia coli*\[[@B12]\] and *Rickettsia prowazekii*\[[@B13]\] show a marked preference for Ap~5~A.

More recently, distinct members of the Nudix family that prefer Ap~6~A have been purified and characterised. The three human enzymes termed diphosphoinositol polyphosphate phosphohydrolases 1 \[[@B14],[@B15]\], 2α and 2β \[[@B16]\] (hDIPP-1, -2α and -2β) as well as *Schizosaccharomyces pombe* Aps1 \[[@B17]\] and *Saccharomyces cerevisiae* Ddp1p \[[@B18]\] all favour Ap~6~A over Ap~5~A. Activity with Ap~4~A is lower, and is in fact lacking in the case of Ddp1p. Remarkably these Ap~6~A hydrolases are also able to utilise the structurally unrelated non-nucleotide substrates, diphosphoinositol pentakisphosphate (PP-InsP~5~) and bis-diphosphoinositol tetrakisphosphate (\[PP\]~2~-InsP~4~), hence they are commonly referred to as the DIPP subfamily. These substrates are generally favoured *in vitro*, with *k*~cat~/*K*~m~ ratios being 50--500-fold higher for PP-InsP~5~ compared to Ap~6~A, except for DIPP-2β, which has a significantly reduced relative activity with PP-InsP~5~ compared to the others. The intracellular levels of diphosphoinositol polyphosphates appear to be lower than those of the nucleotide substrates. PP-InsP~5~ levels are often between 1 \[[@B19]\] and 3% \[[@B20],[@B21]\] of the levels of InsP~6~, which has been estimated as being between 15 and 100 μM (see \[[@B22]\]) and \[PP\]~2~-InsP~4~ levels are an order of magnitude lower \[[@B20],[@B21]\], and as such are virtually undetectable in many cell types. PP-InsP~5~ turnover is regulated by the tumour promoter thapsigargin \[[@B19]\], while \[PP\]~2~-InsP~4~ turnover is regulated by cyclic AMP- and cyclic GMP-dependent processes via an undefined mechanism \[[@B23]\]. However, as for the Ap~n~As, no clear functions have yet been found for the diphosphoinositol polyphosphates, although they have been implicated in vesicle trafficking \[[@B24]\], apoptosis \[[@B25]\] and DNA repair \[[@B26]\].

We describe here two further members of the human DIPP subfamily with novel properties. These proteins, hAps1 and hAps2, products of the *NUDT11* and *NUDT10* genes respectively, closely resemble the other DIPPs in primary structure, but show a selectivity towards Ap~5~A and Ap~6~A and reduced activity towards PP-InsP~5~ and \[PP\]~2~-InsP~4~. They also display a novel pattern of tissue-specific expression.

Results
=======

Sequence alignment
------------------

An initial BLAST search of the GenBank expressed sequence tag (EST) database with the hDIPP-1 sequence identified two closely related but previously uncharacterised predicted proteins, which we have called hAps1 and hAps2 ([h]{.ul}uman [Aps]{.ul}ixA hydrolases [1]{.ul} and [2]{.ul}). Alignment of the cDNA sequences with the human genome indicated that the genomic sequences encoding these proteins, FLJ10628 and LOC139770, lie about 150 kb apart on the X chromosome at Xp11.23 and are transcribed in opposite directions (Fig. [1](#F1){ref-type="fig"}). In accordance with the guidelines for the Nudix protein family, the genes for hAps1 and hAps2 have been designated *NUDT11* and *NUDT10* respectively by the HUGO Gene Nomenclature Committee (see <http://www.gene.ucl.ac.uk/nomenclature/genefamily/npym.html>). These proteins are each 164 amino acids long and are most similar to hDIPP-2β, hAps1 showing 76, 90 and 91% identity at the amino acid level to hDIPP-1, 2α and 2β, respectively. In particular, they both possess the additional Gln residue (Q86 in DIPP-2β) that distinguishes hDIPP-2β from hDIPP-2α and hDIPP-1 and which is responsible for the reduced activity of hDIPP-2β towards diphosphoinositol polyphosphates compared to the other DIPPs. hAps1 and hAps2 are also identical to the hDIPP-2 enzymes throughout the Nudix motif (Fig. [2](#F2){ref-type="fig"}). These observations led us to anticipate that hAps1 and hAps2 would be potent dinucleoside polyphosphate hydrolases with reduced activity towards diphosphoinositol polyphosphates. The existence of two such similar expressed gene products was surprising. Comparison of the open reading frames (ORFs) of hAps1 and hAps2 revealed 6 differences at the nucleotide level, leading to five silent changes (T8, E28, E69, D88 and stop), and an Arg-Pro substitution at position 89. A comparison of the cDNAs for the two gene products showed further divergence in the 3\' untranslated region. It appears that the evolution of these closely related genes occurred recently, as hAps1 and hAps2 show greater similarity with each other than with the Aps-like sequences from mouse (of which two genes, XM_135784 and XM_135786 appear to yield the same protein product) or cow (Fig [3](#F3){ref-type="fig"}). Further examination of all available hAps1 ESTs revealed a sequence divergence, leading to a point mutation S39N, in the coding region. This is present in two ESTs (Table [1](#T1){ref-type="table"}) and was detected in 10% (3 from 30) of polymerase chain reaction (PCR) products generated from a range of normal human cDNA samples from diverse sources. In all other respects investigated, including the 3\' untranslated region, it appeared to be identical to hAps1. This would suggest that this minor variant, hAps1-39N, represents a polymorphism present in the human population. Its properties were also examined in this study.

![**The *NUDT11*/*NUDT10* region of chromosome Xp11.23.** The two known exons of *NUDT11*, encoding hAps1, and *NUDT10*, encoding hAps2 are shown represented as boxes. Introns are represented by angled connecting lines. The coding region of each gene is shaded. Solid arrows indicate the direction of transcription of each gene.](1471-2091-3-20-1){#F1}

![**Sequence alignment of hAps1, hAps2, hDIPP-1 and hDIPP-2 (α and β).** The figure shows an alignment of the amino acid sequences of hAps1, hAps2, hDIPP-1 and hDIPP-2 (α and β), generated by the MAP algorithm. Black shading denotes amino acids in at least two of the proteins were identical. Physicochemical similarity is denoted by grey shading.](1471-2091-3-20-2){#F2}

![**Comparison of hAps1 with translated EST sequences from mouse and cow.** No full-length bovine EST for the hAps1 homologue is available, hence the composite of two separate sequences is shown. A predicted rat protein from genomic sequencing is also shown.](1471-2091-3-20-3){#F3}

###### 

Tissue sources of known ESTs for hAps1 and hAps2

  Tissue            hAps1                               hAps2
  ----------------- ----------------------------------- ------------------------
  Brain             15434059^a^, hippocampus, hAps1     15936725, medulla
                    15495588, hypothalamus, hAps1       13980266, hypothalamus
                                                        15743679, pooled brain
  Testis            14001386, hAps1                     14083118
  Breast            15996913, hAps1                     
  Ovary             19353207, hAps1                     18780184
  Uterus            11970540, tumour cell line, hAps1   
  Eye               19049709, hAps1                     
  Teratocarcinoma   7022778, 10989803, hAps1-39N        

^a^Numbers are GenBank gene identifiers

Purification and properties of hAps1 and hAps2
----------------------------------------------

The ORFs for hAps1, hAps1-39N and hAps2 were cloned into the pGEX6P-1 expression vector and expressed in *Escherichia coli (E. coli)*. After incubation with isopropyl β-D-thiogalactoside (IPTG) (100 μM) at 26°C for 8 hours, a major protein of the expected size was induced and expressed in a soluble form in each case. The glutathione S-transferase (GST)-tagged recombinant proteins were purified by chromatography on Glutathione Sepharose 4 Fast Flow resin (Fig. [4](#F4){ref-type="fig"}).

![**SDS-PAGE of purified hAps1, hAps1-39N and hAps2.** GST-tagged hAps proteins were prepared as described under \"Materials and methods\". Approximately 10 μg of (a) hAps1, (b) hAps1-39N and (c) hAps2 were analysed by SDS-PAGE. Purity was determined by Coomassie-blue staining a 4--12% Bis-Tris NuPage gel (Novex). Molecular weight standards (MultiMark multi-colored standards) were from Novex.](1471-2091-3-20-4){#F4}

Initially, the ability of hAps1 and hAps2 to metabolise Ap~5~A was determined at 37°C in the presence of 50 mM HEPES, pH 7.6 and 100 μM substrate. A divalent cation was essential for activity, with Mn^2+^ by far the most effective between 2 and 6 mM (Fig. [5a](#F5){ref-type="fig"}). Cu^2+^ supported less than 30% and Zn^2+^ and Co^2+^ each less than 3% of the maximum activity. Ni^2+^, Ca^2+^ and, surprisingly, Mg^2+^ were unable to activate hAps1 or hAps2. When assayed in the presence of 1 mM MnCl~2~, hAps1 and hAps2 showed alkaline pH optima of pH 8.5 (Fig. [5b](#F5){ref-type="fig"}), a feature common among Nudix hydrolases. Activity increased from undetectable at pH 6 to over 70% maximum between 7.5 and 9. Previous characterisation of hDIPP-1, 2α and 2β, as well as *S. pombe* Aps1 was performed in a buffer containing 1 mM MnCl~2~ at pH 7.6. In order to compare results for hAps1 and hAps2 directly with hDIPP-1, hDIPP-2 and *S. pombe* Aps1, we have performed assays using identical conditions.

![**Properties of hAps1 and hAps2.** (a) Mn^2+^-dependency of hAps1 (filled circles) and hAps2 (open circles) activity towards Ap~5~A (100 μM). (b) pH dependency of hAps1 (filled circles) and hAps2 (open circles) activity towards Ap~5~A (100 μM).](1471-2091-3-20-5){#F5}

When hAps1, hAps1-39N and hAps2 were assayed with a wide range of potential substrates all three proteins were found, as expected, to metabolise Ap~5~A and Ap~6~A. Of the other substrates tested, only p~4~A and p~4~G showed significant rates of hydrolysis by all three, while Ap~4~A and Gp~4~G were also effective substrates for hAps2. All three enzymes showed a marked preference for adenine over guanine nucleotides. Table [2](#T2){ref-type="table"} shows rates of metabolism and products formed where identified. *K*~m~ and *k*~cat~ values for each enzyme with Ap~5~A and Ap~6~A are shown in Table [3](#T3){ref-type="table"}. The most rapidly metabolised substrate appeared to be Ap~5~A, although Ap~6~A was bound with higher affinity.

###### 

Nucleotide substrate utilisation by hAps1, hAps1-39N and hAps2

  Nucleotide    Rate (nmol/min/μg)   Major products                 
  ------------- -------------------- ---------------- ------------- ---------------
                hAps1                hAps1-39N        hAps2         
                                                                    
  Ap~6~A        0.25 ± 0.04          0.19 ± 0.01      0.28 ± 0.04   AMP + p~5~A
  Ap~5~A        0.41 ± 0.05          0.37 ± 0.02      0.9 ± 0.1     AMP + p~4~A
  Ap~4~A        0.02 ± 0.01          0.02 ± 0.01      0.09 ± 0.03   AMP + ATP
  Ap~3~A        0                    0                0             
  Ap~2~A        0                    0                0             
  Gp~5~G        0.04 ± 0.02          0.02 ± 0.01      0             
  Gp~4~G        0.04 ± 0.02          0.04 ± 0.02      0.11 ± 0.04   GMP, GDP, GTP
  Gp~3~G        0                    0                0             
  Gp~2~G        0                    0                0             
  Ap~5~G        0                    0                0             
  Ap~4~G        0                    0                0             
  p~4~A         0.07 ± 0.03          0.10 ± 0.03      0.13 ± 0.04   ATP
  ATP           0                    0.03 ± 0.02      0             
  ADP-ribose    0                    0                0             
  ADP-glucose   0                    0                0             
  dATP          0                    0.07 ± 0.04      0             
  p~4~G         0.15 ± 0.05          0.21 ± 0.05      0.21 ± 0.03   GTP
  GTP           0.02 ± 0.01          0.03 ± 0.01      0             
  GDP-glucose   0.01 ± 0             0                0             
  GDP-mannose   0                    0                0             
  dGTP          0.05 ± 0.03          0.05 ± 0.03      0             
  dUTP          0.04 ± 0.03          0.05 ± 0.02      0             
  dTTP          0.05 ± 0.04          0.05 ± 0.03      0             
  CTP           0.03 ± 0.02          0.03 ± 0.02      0             

###### 

Kinetic parameters of hAps1, hAps1-39N and hAps2

  Enzyme      Substrate            *K*~m~ (μM)   *k*~cat~ (s^-1^)   *k*~cat~/*K*~m~ (10^3^M^-1^s^-1^)
  ----------- -------------------- ------------- ------------------ -----------------------------------
  hAps1       Ap~6~A               13 ± 5        0.17 ± 0.04        13.1
              Ap~5~A               37 ± 9        0.4 ± 0.1          10.8
              PP-InsP~5~ (n = 2)   4             0.20               50
  hAps1-39N   Ap~6~A               11 ± 3        0.16 ± 0.02        14.5
              Ap~5~A               50 ± 10       0.4 ± 0.1          8.0
              PP-InsP~5~ (n = 2)   0.3           0.09               290
  hAps2       Ap~6~A               19 ± 1        0.20 ± 0.01        10.5
              Ap~5~A               50 ± 10       0.8 ± 0.2          16.0
              PP-InsP~5~           1.3 ± 0.6     0.14 ± 0.02        110

Prolonged treatment of Ap~6~A and Ap~5~A identified the major products as adenosine 5\'-monophosphate (AMP) plus adenosine 5\'-pentaphosphate (p~5~A) and AMP plus adenosine 5\'-tetraphosphate (p~4~A) respectively. In neither case did p~5~A or p~4~A accumulate as these are metabolised almost as rapidly as they are formed, p~5~A being hydrolysed sequentially to p~4~A then ATP. In this respect, hAps1 and hAps2 show similar modes of action to hDIPP-1 \[[@B15]\] and hDIPP-2 (S.T. Safrany, data not shown). Nudix hydrolases have been found to be sensitive to inhibition by fluoride. Hydrolysis of Ap~5~A by hAps1 and hAps2 was found to be inhibited non-competitively with *K*~i~ values of 13.0 ± 0.5 and 30 ± 1 μM respectively (data not shown).

Despite the overall high degree of sequence similarity between hAps1, hAps2 and the DIPPs, hAps1 and hAps2 were found to have little activity towards PP-InsP~5~ or \[PP\]~2~-InsP~4~. hAps1 and hAps1-39N showed first order rate constants (*k*^-1^) with PP-InsP~5~ of 19 ± 4 and 7 ± 5 μg^-1^min^-1^ respectively. Activity of hAps2 was similar to that of hAps1, with a *k*^-1^ = 13 ± 6 μg^-1^min^-1^. These compare with *k*^-1^ values of 2200, 2000 and 220 μg^-1^min^-1^ for hDIPP-1, -2α and -2β respectively \[[@B16]\]. *K*~m~ and *k*~cat~ values were determined for each of the proteins (Table [3](#T3){ref-type="table"}) and these suggested that the reduction in activity towards PP-InsP~5~ compared with hDIPP-1 and hDIPP-2α was primarily due to a reduced affinity for this substrate. Activity towards \[PP\]~2~-InsP~4~ was even weaker. hAps1 and hAps2 gave *k*^-1^ = 1.0 ± 0.2 and 0.9 ± 0.2 μg^-1^min^-1^ respectively. hAps1-39N showed no activity towards \[PP\]~2~-InsP~4~ under the conditions tested. In contrast, hDIPP-1, -2α and -2β gave *k*^-1^ values of 320, 90 and 32 μg^-1^min^-1^ respectively, whereas *S. pombe* Aps1 and *S. cerevisiae* Ddp1p showed similar activity with *k*^-1^ = 8.3 and 1.7 μg^-1^min^-1^ respectively \[[@B15]\].

Tissue distribution
-------------------

Analysis of the tissue distribution of hAps1 and hAps2 gene expression was performed using PCR and human tissue cDNA samples. Using primers selective for hAps1, PCR products were readily visible from brain, pancreas and testis and less so from lung, thymus, prostate, ovary, small intestine and heart (the least) (Fig. [6](#F6){ref-type="fig"}). Selective primers for hAps2 produced strong signals from brain and liver, but also from heart, placenta, lung, kidney, pancreas, spleen, prostate, testis and ovary (Fig. [6](#F6){ref-type="fig"}). No signal for hAps1 was detected in placenta, liver, skeletal muscle, kidney, spleen, colon or peripheral blood leukocytes. Likewise, no signal for hAps2 was found in skeletal muscle, thymus, small intestine, colon or peripheral blood leukocytes. A number of tumour cell line cDNA samples were also tested; hAps1 was present in prostate PC3, and ovary GI-102 cells. The prostate PC3 cell line was also found to express hAps2. Tumour cell lines from breast GI-101, lung LX-1, colon CX-1, lung GI-117, colon GI-112 and pancreas GI-103 were found to express neither hAps1 nor hAps2. These results are in broad agreement with the sources of ESTs for these two protein families (Table [1](#T1){ref-type="table"}). This list is for comparison and is not exhaustive. In contrast, hDIPP-1 was found in all the tissues and cell types tested above (S.T. Safrany, unpublished data).

![**Tissue distribution of hAps1, hAps2 and β-actin.** PCR using human tissue first-strand cDNA as template was performed with primers specific for β-actin and for hAps1 or hAps2. 35 cycles of amplification were used for β-actin, 40 cycles for hAsp1 and hAps2.](1471-2091-3-20-6){#F6}

Whilst an exhaustive analysis has not been performed for hDIPP-2, it was found to be highly expressed in heart, skeletal muscle, kidney and pancreas, and weakly expressed in brain, placenta lung and liver \[[@B16]\].

Subcellular localisation
------------------------

The subcellular localisation of hAps1, hAps1-39N and hAps2 was investigated by individual expression of the three proteins tagged at the N-terminus with EGFP in HEK293 and PC12 cells, and visualisation of the expressed fusion proteins by deconvolved fluorescence microscopy. These results show that in both cell types EGFP-tagged proteins showed a cytosolic location indistinguishable from EGFP-hDIPP-2α, EGFP-hDIPP-2β and EGFP alone (Fig. [7a](#F7){ref-type="fig"} and [7b](#F7){ref-type="fig"}). Similar data were obtained with proteins tagged at the C-terminus with EGFP (data not shown). This is in agreement with localisation predicted using PSORTII.

![**Subcellular localisation of EGFP, EGFP-hDIPP-2 (α and β) and hAps1 and hAps2.** Proteins fused to the C-terminus of EGFP were expressed in (a) HEK293 or (b) PC12 cells for 24 h and visualised by fluorescence microscopy.](1471-2091-3-20-7){#F7}

Discussion
==========

The human genome contains at least 18 Nudix genes, several of which encode multiple products, and 9 Nudix hydrolases have been characterised so far to varying degrees (see <http://www.gene.ucl.ac.uk/nomenclature/genefamily/npym.html>). These include hDIPP-1, hDIPP-2α and hDIPP-2β, encoded by the *NUDT3* (hDIPP-1) and *NUDT4* (hDIPP-2α and hDIPP-2β) genes, all of which hydrolyse both the higher order diadenosine polyphosphates and diphosphoinositol polyphosphates. In this report, we describe the cloning and functional characterisation of hAps1 and hAps2, two new members of the DIPP subfamily with a novel pattern of expression and substrate specificity. A polymorphism of hAps1 (hAps1-39N) has also been found, its activity and localisation appearing broadly similar to those of hAps1. Unlike the other subfamily members, hAps1 and hAps2 show little activity towards diphosphoinositol polyphosphates, both gene products favouring diadenosine polyphosphates, Ap~n~A, where n = 5 or 6. In each case, Ap~6~A binds with higher affinity than Ap~5~A, whereas the *k*~cat~ for the latter is greater. Given that no other PP-InsP~5~ hydrolase activity was observed during the purification of rat hepatic DIPP (most similar to hDIPP-1) and assuming that tissue expression and physiology are broadly conserved between human and rat, these results would suggest that Aps-like proteins do not contribute significantly to inositol phosphate metabolism.

Both hAps1 and hAps2 show typical Nudix hydrolase requirements, namely an alkaline pH optimum *in vitro* and a requirement for divalent cations \[[@B12]\]. An unusual feature of hAps1 and hAps2 is that they both require Mn^2+^ for activation, and that Mg^2+^ is without effect. Optimal \[Mn^2+^\] is approximately 4 mM, which is in contrast to that estimated for free intracellular \[Mn^2+^\] of below 0.5 μM \[[@B27]\]. Free \[Mn^2+^\] in our *in vitro* assays was not determined. It is well acknowledged that Mn^2+^ binds serum albumin very tightly, but despite this we would anticipate free \[Mn^2+^\] in the assays to be far in excess of intracellular levels. It is known that the activity of metal ion-requiring enzymes in different cellular compartments can be regulated through the controlled trafficking of these ions and therefore through the controlled access of these enzymes to their required ions. This principle has been most thoroughly studied in the case of Ca^2+^\[[@B28]\], although analogous observations have been made with Cu^2+^\[[@B29]\] and Mn^2+^\[[@B30]\]. Since the \[Mn^2+^\] throughout the cell is known to be non-uniform, the unusual requirement of the hAps enzymes suggests a possible mechanism of regulation through access to this ion.

Several biochemically distinct Ap~5/6~A hydrolases have been described previously. *S. pombe* Aps1, *S. cerevisiae* Ddp1p and hDIPP-1 and hDIPP-2 have all been shown to metabolise Ap~5~A and Ap~6~A. The activities of hAps1 and hAps2 towards Ap~5~A and Ap~6~A are comparable to hDIPP-1, but their activities towards the diphosphoinositol polyphosphates PP-InsP~5~ and \[PP\]~2~-InsP~4~ are greatly reduced, thus making them some 100--300-fold more selective towards Ap~5~A and Ap~6~A than hDIPP-1 or hDIPP-2. *S. pombe* Aps1 and *S. cerevisiae* Ddp1p, the sole representatives of the DIPP subfamily in the two yeast genomes, appear to favour the diphosphoinositol polyphosphates. Their modes of action have been shown to differ from their mammalian counterparts. The major products of Ap~6~A hydrolysis by *S. pombe* Aps1 and *S. cerevisiae* Ddp1p are ADP and p~4~A \[[@B17],[@B18]\]. As with hDIPP-1 \[[@B15]\] and hDIPP-2 (Safrany, data not shown), hAps1 and hAps2 produced AMP and p~5~A as major products. With Ap~5~A as substrate, *S. pombe* Aps1 favoured the production of ADP plus ATP, whereas *S. cerevisiae* Ddp1p favoured production of AMP and p~4~A. In this respect hAps1 and hAps2 as well as hDIPP-1 and hDIPP-2 resemble Ddp1p.

Due to the chromosomal proximity of Aps1 and Aps2, and the greater degree of sequence identity with each other than with the Aps-like genes from mouse, rat or cow, it seems likely that this gene pair has arisen as the result of a recent gene duplication event on the short arm of the X chromosome \[[@B31]\]. A popular view of the evolution of catalytic motifs envisages the duplication of relatively non-specific progenitors followed by adaptation to perform special tasks, and the Nudix hydrolase motif appears to be a good illustration of this process. The existence of multiple forms of these enzymes would suggest that the diadenosine polyphosphates have significant biological functions, with the specialised task of hAps1 and/or hAps2 being the regulation of Ap~5~A and Ap~6~A levels.

Conclusions
===========

Previously, the human DIPP family comprised hDIPP-1, a ubiquitous enzyme able to hydrolyse both inositol phosphates and diadenosine polyphosphates, and hDIPP-2α and -2β, which are predominantly diphosphoinositol polyphosphate phosphohydrolases highly expressed in heart, skeletal muscle, kidney and pancreas. We have now identified two further members, hAps1 and hAps2, which have high selectivity towards the diadenosine polyphosphates. The distinction between DIPP and Ap~n~A hydrolase activities reinforces the importance of Q86 in DIPP-2β and the role of Q85 in hAps1 and hAps2. The addition of this amino acid in hDIPP-2 has been previously shown to have a substantial negative effect upon its activity towards diphosphoinositol polyphosphates, whereas Ap~5~A hydrolase activity was increased. The expression of hAps1 and hAps2 is also restricted. Of the tissues tested, only pancreas showed high levels of hDIPP-2 and hAps1, and only heart showed high levels of hDIPP-2 and hAps2, although ESTs were found suggesting that hDIPP-2 is expressed in testis, ovary and prostate. The presence of hAps1 and hAps2 in such a variety of tissues suggests that Ap~5~A and Ap~6~A may have roles other than as secreted molecules. We find that hAps1 is present in the pancreas, but there is no suggestion that it is secreted. For this reason, hAps1 and hAps2 are expected to control intracellular Ap~5~A and Ap~6~A levels.

In conclusion, we have identified two human Nudix hydrolases that share a novel substrate specificity, metabolising predominantly Ap~5~A and Ap~6~A. These two gene products complement the activity of previously described members of the DIPP family, and reinforce the concept of Ap~5~A and Ap~6~A acting as intracellular messengers.
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Materials and Methods
=====================

Materials
---------

Ap~4~G, Ap~5~G and p~4~A were purchased from Jena Bioscience, Jena, Germany. Other nucleotides were purchased from Sigma. Non-radioactive PP-InsP~5~ was a kind gift from J.R. Falck (University of Texas Southwestern Medical Center, Dallas, TX, USA). \[^3^H\]-PP-InsP~5~ and \[^3^H\]-\[PP\]~2~-InsP~4~ were prepared as previously described \[[@B15]\].

Cloning and plasmid construction
--------------------------------

PCR products corresponding to the hAps1 sequence were amplified from a human testis library (Clontech), using the primers SSD019 (5\'-ggca[ggatcc]{.ul}aagtgcaaacccaaccagacg-3\') and SSD020 (5\'-ggca[ggatcc]{.ul}ttagggatcgctatctggcg-3\') (*Bam*HI sites are underlined). PCR was carried out using a HiFidelity Expand Kit (Roche), and the products cloned into the vector pCR2.1TOPO (Invitrogen) and sequenced. Surprisingly, three variant sequences were found (termed hAps1, hAps1-39N and hAps2). These were subcloned as *Bam*HI fragments into the *Bam*HI site of pGEX-6P1 (Amersham Pharmacia Biotech) (starting at K2, to compare with K3 of hDIPP-1 and hDIPP-2) and fully re-sequenced. The 3\' nucleotide of SSD019 introduced a silent mutation into hAps2, and was allowed to remain. Likewise, SSD020 also introduced a silent mutation into the stop codon of hAps2. This was also allowed to remain. Vectors for the expression of Nudix hydrolase proteins fused to the C-terminus of Enhanced Green Fluorescent Protein (EGFP) were produced by ligating a cDNA encoding each protein as a *Bam*HI digestion fragment from the GST-fusion vectors described above, into pEGFP-C1 (Clontech) previously digested with *Bgl*II and *Bam*HI.

Bioinformatics
--------------

Multiple sequence alignments were performed using MAP and BoxShade, both run by EMBnet, Lausanne, Switzerland. Blast searches of EST and genomic databases were performed using the facilities provided by NCBI, Bethesda, MD, USA.

Expression and purification of hAps1, hAps1-39N and hAps2
---------------------------------------------------------

Full-length hAps1, hAps1-39N and hAps2 were expressed and purified from *E. coli* as GST-fusion proteins. Expression plasmids based on pGEX-6P1 were transformed into *E. coli* strain BL21, and induced at 26°C overnight with 100 μM IPTG. Cells were harvested in buffer A (20 mM Tris, 150 mM NaCl, 2 mM DTT, 0.1 mM EGTA, pH 7.5), supplemented with 5 μg/ml leupeptin and 1 μg/ml aprotinin, and disrupted by sonication (3 × 15s). Particulate matter was removed by centrifugation. The supernatant was applied to (and subsequently eluted from) a 5 mm × 5 cm Glutathione Sepharose 4 Fast Flow column (Amersham Pharmacia Biotech) at a flow rate of 1 ml/min. The column was washed for 5 min with buffer A. Bound protein was eluted with a gradient generated by mixing buffer A with buffer B (buffer A plus 25 mM glutathione, pH 7.5) as follows: 0-10 min, 0-50% buffer B; 10-13 min, 100% buffer B. Fractions containing pure hAps1, hAps1-39N or hAps2 were supplemented with glycerol (10% v/v final), and stored at -80°C.

Tissue distribution
-------------------

The tissue distribution of hAps1 and hAps2 expression was determined by PCR from human tissue cDNA samples (human cDNA panels, Clontech) and human cDNA libraries (testis from Clontech, brain from Dr Peter Cheung of the MRC Protein Phosphorylation Unit, Wellcome Trust Biocentre, Dundee, Scotland, UK). β-Actin-specific and hAps1 and hAps2-specific primers were used. The hAps1 primers were SSD049 (5\'-cgtcttcgaacagaaccaggatcg-3\'), and SSD045 (5\'-caaaagccacacacatggtgcc-3\') and the hAps2 primers were SSD050 (5\'-cgtcttcgaacagaaccaggaccc-3\') and SSD046 (5\'-gtgcaacaacctggagaatagtcattgta-3\'). Primers SSD045 and SSD046 were selective for the 3\' untranslated regions of hAsp1 and hAsp2 respectively. β-Actin cDNA was amplified using β AS (5\'-acactgtgcccatctacgaggg-3\') and β AA (5\'ccttctgcatcctgtcagcaatg-3\'). PCR was carried out using a HiFidelity Expand Kit (Roche), and cDNA samples from heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas (human MTC panel I \#K1420-1, Clontech), spleen, thymus, prostate, testis, ovary, small intestine, colon, peripheral blood leukocytes (human MTC Panel II \#K1421-1, Clontech). The following tumour cell lines were also tested: breast GI-101, lung LX-1, colon CX-1, lung GI-117, prostate PC3, colon GI-112, ovary GI-102 and pancreas GI-103 (human MTC Tumor Panel \#K1422-1, Clontech).

Subcellular localisation
------------------------

The subcellular localisation of hAps1, hAps1-39N and hAps2 proteins fused to EGFP was investigated using transfected HEK 293 epithelial cells and PC12 pheochromocytoma cells. PC12 cells were grown in DMEM/5% foetal bovine serum/5% horse serum. HEK293 were grown in DMEM/10% foetal bovine serum. Both cell types were grown on coverslips and transfected using Fugene-6 (Roche) with expression vectors for each Nudix hydrolase fused to the C-terminus of EGFP. 24 hours after transfection, cells were observed using a Leica inverted stage fluorescence microscope and a Hamamatsu Orca charge-coupled-device camera. Images were analysed using Improvision OpenLab deconvolution software.

Enzyme assays
-------------

For the analysis of nucleotide metabolism, assays were performed as previously described \[[@B15]\], unless otherwise stated. The UV-absorbing (260 nm) nucleotide reaction products were analysed using a 4.6 × 125 mm Partisphere 5 μm SAX HPLC column. Substrates and products were eluted at 1 ml/min by the following gradient generated by mixing water with buffer C (1.3 M (NH~4~)~2~HPO~4~, pH 4.8 with H~3~PO~4~): 0-5 min, 0% buffer C; 5-55 min, 0-50% buffer C; 56-70 min, 0% buffer C. pH optima of recombinant enzymes were determined in a series of buffers comprising 1 mM MnCl~2~, 100 μg/ml BSA and 15 mM MES, 15 mM HEPES or 15 mM Tris (pH 6-9 with HCl or NaOH). Divalent ion-dependency was determined in a buffer comprising 50 mM HEPES, 100 μg/ml BSA, pH 7.6, and 50 μM-10mM (where possible) divalent metal as the chloride salt. Inositol phosphate metabolism was determined exactly as described previously \[[@B14]\]. *K*~m~ and *k*~cat~ values were determined by hyperbolic regression analysis.
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During the reviewing of this manuscript a paper was submitted and accepted in the Journal of Biological Chemistry (K Hidaka, JJ Caffrey, L Hua, T Zhang, JR Falck, GC Nickel, L Carrel, LD Barnes, SB Shears: An adjacent pair of human NudT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase. *J Biol Chem* in press). DIPP-3β corresponds to hAps1, whereas DIPP-3α corresponds to hAps2.
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